DexCom Inc (DXCM) stock news · P/E 35, rev $4.66B
DexCom Inc (DXCM) is a medical devices company listed on US.
This DXCM news page leads with what DexCom Inc filed — not a scraped headline mill.
No cached 8-K sentence for DXCM yet. We will not pad this page with generic market recap.
Latest reported DXCM revenue for 2025-12-31 was $4.66B. Net income was $836.3M. Revenue was up 15.6% from 2024-12-31 to 2025-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 34.6.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DXCM stock page; for the tape open the quote page.
DXCM stock news FAQ
What are DXCM's latest revenue and net income?
Latest cached DexCom Inc (DXCM) revenue for Dec 31, 2025 was $4.66B. Net income was $836.3M. Statements: https://lician.com/financials/dxcm
How did DXCM revenue change from the prior cached period?
Cached DexCom Inc (DXCM) revenue was up 15.6% from $4.03B (Dec 31, 2024) to $4.66B (Dec 31, 2025). Statements: https://lician.com/financials/dxcm
What is DXCM's P/E ratio?
DexCom Inc (DXCM) trailing P/E is 34.6 on the latest cached fundamentals snapshot.
What is DXCM's market cap?
DexCom Inc (DXCM) market cap is $32.84B on the latest cached fundamentals snapshot.
What kind of company is DXCM?
DexCom Inc (DXCM) is a medical devices company listed on US.
Where is DXCM stock news listed?
Cached stock news for DexCom Inc (DXCM) is listed at https://lician.com/news/dxcm. Filings: https://lician.com/sec/dxcm
Not investment advice.